PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canada

Autor:	K.C. Young, H. Sandhu, A. Lee, K. Lakhdari, J. Maervoet, C. Jones, Y. Yuan, M. Chaudhary, J.R. Penrod, N. Varol
Rok vydání:	2021
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 24:S53
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.274
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a16e9a20a48196b143ec99fca597a031 https://doi.org/10.1016/j.jval.2021.04.274 Zobrazit plný text záznamu Full Text from ScienceDirect